bOur study is the first to compare the nasopharyngeal microbiota of pediatric pneumonia patients and control children by 454 pyrosequencing. A distinct microbiota was associated with different pneumonia etiologies. Viral pneumonia was associated with a high abundance of the operational taxonomic unit (OTU) corresponding to Moraxella lacunata. Patients with nonviral pneumonia showed high abundances of OTUs of three typical bacterial pathogens, Streptococcus pneumoniae complex, Haemophilus influenzae complex, and Moraxella catarrhalis. Patients classified as having no definitive etiology harbored microbiota particularly enriched in the H. influenzae complex. We did not observe a commensal taxon specifically associated with health. The microbiota of the healthy nasopharynx was more diverse and contained a wider range of less abundant taxa. P neumonia is the leading cause of childhood mortality worldwide, claiming 2 million lives yearly among young children (1). The etiology of pediatric pneumonia is complex and not routinely determined in clinical practice (2). Its definitive determination remains challenging (3). Clinical research shows that Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus are the leading pathogens of bacterial pneumonia (1, 4). Respiratory syncytial virus (RSV), parainfluenza, and influenza viruses are the main causes of pediatric viral pneumonia (e.g., see references 5 and 6). S. pneumoniae and H. influenzae frequently colonize the nasopharynx of young children, and the nasopharyngeal (NP) carriage of S. pneumoniae is considered key to pneumonia and other pneumococcal diseases (7). However, the mere nasopharyngeal presence of bacterial pathogens does not necessarily lead to invasive lung infection. Various mechanisms, such as competition with resident nonpathogenic microbiota, viral coinfection, or host immune factors are likely to affect the transition from nasopharyngeal colonization to pneumonia (8). The increasing accessibility of culture-independent sequencing methods has permitted microbiota description at various body sites (9), and the potential of commensal microbiota to modify the disease process is receiving increasing attention (10).Previous culture-independent studies of the nasopharyngeal microbiota of young children looked at healthy children (11) and compared the microbiota composition of healthy children and children with acute otitis media (12). In the present study, we analyzed the nasopharyngeal microbiota composition, including the presence of respiratory viruses, in pediatric pneumonia patients and matched healthy controls and looked for microbiota associations with the disease status. MATERIALS AND METHODS Patients and clinical samples.A prospective case-control study conducted in 2008 to 2009 in 3 major hospitals in Switzerland (Geneva, Lausanne, and Sion) to investigate pediatric community-acquired pneumonia etiology was described in detail elsewhere (13). Briefly, pneumonia cases were diagnosed according to the WHO criteria (14) in children 2 ...
BackgroundInflammatory bowel diseases (IBD) are chronic intestinal inflammatory diseases affecting about 1% of western populations. New eating behaviors might contribute to the global emergence of IBD. Although the immunoregulatory effects of omega-3 fatty acids have been well characterized in vitro, their role in IBD is controversial.MethodsThe aim of this study was to assess the impact of increased fish oil intake on colonic gene expression, eicosanoid metabolism and development of colitis in a mouse model of IBD. Rag-2 deficient mice were fed fish oil (FO) enriched in omega-3 fatty acids i.e. EPA and DHA or control diet for 4 weeks before colitis induction by adoptive transfer of naïve T cells and maintained in the same diet for 4 additional weeks. Onset of colitis was monitored by colonoscopy and further confirmed by immunological examinations. Whole genome expression profiling was made and eicosanoids were measured by HPLC-MS/MS in colonic samples.ResultsA significant reduction of colonic proinflammatory eicosanoids in FO fed mice compared to control was observed. However, neither alteration of colonic gene expression signature nor reduction in IBD scores was observed under FO diet.ConclusionThus, increased intake of dietary FO did not prevent experimental colitis.
Phospholipids (PL) or partial acylglycerols such as sn-1(3)-monoacylglycerol (MAG) are potent dietary carriers of long-chain polyunsaturated fatty acids (LC-PUFA) and have been reported to provide superior bioavailability when compared to conventional triacylglycerol (TAG). The main objective of the present study was to compare the incorporation of docosahexaenoic acid (DHA) in plasma, erythrocytes, retina and brain tissues in adult rats when provided as PL (PL-DHA) and MAG (MAG-DHA). Conventional dietary DHA oil containing TAG (TAG-DHA) as well as control chow diet were used to evaluate the potency of the two alternative DHA carriers over a 60-day feeding period. Fatty acid profiles were determined in erythrocytes and plasma lipids at time 0, 7, 14, 28, 35 and 49 days of the experimental period and in retina, cortex, hypothalamus, and hippocampus at 60 days. The assessment of the longitudinal evolution of DHA in erythrocyte and plasma lipids suggest that PL-DHA and MAG-DHA are efficient carriers of dietary DHA when compared to conventional DHA oil (TAG-DHA). Under these experimental conditions, both PL-DHA and MAG-DHA led to higher incorporations of DHA erythrocytes lipids compared to TAG-DHA group. After 60 days of supplementation, statistically significant increase in DHA level incorporated in neural tissues analyzed were observed in the DHA groups compared with the control. The mechanism explaining hypothetically the difference observed in circulatory lipids is discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.